ARCHIVES

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Alternative Medicine: Testing The Boundaries Of Science

May 15, 1998

ONS Adopts Scope Of Oncology Nursing Practice

November 23, 1984

Zevalin Regimen Better Than Rituximab Alone For NHL

June 29, 2001

Becker, Brown Testify On Biomedical Funding, Manpower Needs

March 23, 1990

NIH, NCI Get Higher Funding In 2014 Budget

January 17, 2014

Six Comprehensive Center Asked By Candlelighters For Pediatric Cancer

March 24, 1978